Amvuttra approved for expanded use in rare heart diseaseA
Continue reading...
Amvuttra approved for expanded use in rare heart disease
Amvuttra approved for expanded use in rare heart disease
The U.S. Food and Drug Administration (FDA) on Thursday approved Alnylam Pharmaceuticals’ Amvuttra/Vutrisiran to treat a...